Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_44808 | 20 | 0.41 | Mlig455_013291 | Neo: - Age: - |
Mlig455_013291 {REF} {Length: 1358} {RNA1310_28961.1} {RNA815_27532} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 3.027 | 0.849 | 0.99985 | 1.00000 | |
RegionR2 | 2.826 | 0.849 | 0.99929 | 1.00000 | |
RegionR3 | -0.028 | 0.849 | 0.94544 | 1.00000 | |
RegionR4 | 0.456 | 0.849 | 1.00000 | 1.00000 | |
RegionR5 | -1.534 | 0.849 | 0.85465 | 1.00000 | |
RegionR6 | -2.648 | 0.849 | 0.99964 | 1.00000 | |
RegionR7 | -1.197 | 0.849 | 0.99990 | 1.00000 | |
RegionR8 | -0.9 | 0.849 | 0.99982 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -4.301 | 0.849 | 0.99987 | 1.00000 | |
RegenerationR2 | -1.102 | 0.849 | 0.43296 | 0.83598 | |
RegenerationR3 | -3.865 | 0.849 | 0.00435 | 0.11961 | |
RegenerationR4 | -1.842 | 0.849 | 0.99613 | 1.00000 | |
RegenerationR5 | -1.889 | 0.849 | 0.08616 | 0.45242 | |
RegenerationR6 | 1.295 | 0.849 | 0.89885 | 1.00000 | |
RegenerationBL | -1.773 | 0.849 | 0.99990 | 1.00000 | |
RegenerationTP | -1.66 | 0.849 | 0.99973 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_44808 | 20 | 0.41 | Mlig455_013291 | Neo: - Age: - |
3 | 1.000 | - | 1.000 | - | 1.000 | - | Mlig455_013291 {REF} {Length: 1358} {RNA1310_28961.1} {RNA815_27532} | |
2. | MligTC455_17561 | 189 | 3.94 | Mlig455_020268 | Neo: - Age: - Region-enriched R2: 4.198/0.00004 |
NECAB3 | 2.811 | 0.988 | - | 0.854 | - | 0.969 | - | Mlig455_020268 {REF} {Length: 1518} {Pfam: EF hand [PF00036.34, score=34.0]; EF-hand domain [PF13405.8, score=33.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF-hand domain pair [PF13499.8, score=28.3]; Antibiotic biosynthesis monooxygenase [PF03992.18, score=22.0]; EF hand [PF13202.8, score=21.3]} {Human: ENSG00000125967, NECAB3, N-terminal EF-hand calcium binding protein 3, [RH, Score=189, Expect=7e-57]; ENSG00000123119, NECAB1, N-terminal EF-hand calcium binding protein 1, [RH, Score=186, Expect=1e-55]} {Mouse: ENSMUSG00000040536, Necab1, N-terminal EF-hand calcium binding protein 1, [RH, Score=192, Expect=6e-58]; ENSMUSG00000027489, Necab3, N-terminal EF-hand calcium binding protein 3, [RH, Score=191, Expect=9e-58]} {RNA1509_46831} {RNA1310_24461, RNA1509_46831} {RNA1509_46831, RNA815_25216} |
3. | MligTC455_27203 | 178 | 3.7 | Mlig455_056778 | Neo: - Age: - Region-enriched R5: 2.470/0.02695 |
ACTG1 | 2.798 | 0.930 | - | 0.900 | - | 0.968 | - | Mlig455_056778 {REF} {Length: 10764} {Pfam: Actin [PF00022.21, score=469.5]; RIH domain [PF01365.23, score=52.7]; Integrase core domain [PF00665.28, score=48.1]; Inositol 1,4,5-trisphosphate/ryanodine receptor [PF08709.13, score=37.6]; MIR domain [PF02815.21, score=36.4]; RyR and IP3R Homology associated [PF08454.13, score=29.4]; Ion transport protein [PF00520.33, score=19.1]} {Human: ENSG00000184009, ACTG1, actin gamma 1, [Score=710, Expect=0.0]; ENSG00000075624, ACTB, actin beta, [Score=708, Expect=0.0]; ENSG00000107796, ACTA2, actin, alpha 2, smooth muscle, aorta, [Score=689, Expect=0.0]; ENSG00000159251, ACTC1, actin, alpha, cardiac muscle 1, [Score=689, Expect=0.0]; ENSG00000163017, ACTG2, actin, gamma 2, smooth muscle, enteric, [Score=689, Expect=0.0]; ENSG00000143632, ACTA1, actin, alpha 1, skeletal muscle, [Score=688, Expect=0.0]; ENSG00000169067, ACTBL2, actin, beta like 2, [Score=681, Expect=0.0]} {Mouse: ENSMUSG00000062825, Actg1, actin, gamma, cytoplasmic 1, [Score=710, Expect=0.0]; ENSMUSG00000029580, Actb, actin, beta, [Score=708, Expect=0.0]; ENSMUSG00000035783, Acta2, actin, alpha 2, smooth muscle, aorta, [Score=689, Expect=0.0]; ENSMUSG00000059430, Actg2, actin, gamma 2, smooth muscle, enteric, [Score=689, Expect=0.0]; ENSMUSG00000068614, Actc1, actin, alpha, cardiac muscle 1, [Score=689, Expect=0.0]; ENSMUSG00000031972, Acta1, actin, alpha 1, skeletal muscle, [Score=688, Expect=0.0]; ENSMUSG00000055194, Actbl2, actin, beta-like 2, [Score=687, Expect=0.0]} {Dmel: FBgn0000044, Act57B, Actin 57B, [Score=708, Expect=0.0]} {Celegans: WBGene00000065, act-3, Actin-1, [Score=711, Expect=0.0]} {Smed: dd_Smed_v6_3_0_1, dd_Smed_v6_3_0_1, [Score=702, Expect=0.0]} {RNA1509_59019} {RNA1310_34487} {RNA815_14388} |
4. | MligTC455_37286 | 90 | 1.88 | Mlig455_025470, Mlig455_071141 | Neo: - Age: - |
GRIA2 | 2.768 | 0.892 | - | 0.992 | - | 0.884 | - | Mlig455_025470 {REF} {Length: 3546} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.9]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=120, Expect=2e-27]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=119, Expect=7e-27]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=117, Expect=4e-26]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=116, Expect=6e-26]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=115, Expect=1e-25]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=115, Expect=2e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=118, Expect=1e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=118, Expect=9e-27]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=117, Expect=2e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=116, Expect=4e-26]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=116, Expect=4e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=115, Expect=6e-26]} {Dmel: FBgn0038837, CG3822, [Score=153, Expect=5e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=9e-67]} {RNA1310_33468} Mlig455_071141 {REF} {Length: 3783} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.8]; Receptor family ligand binding region [PF01094.30, score=50.3]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=118, Expect=2e-26]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=118, Expect=2e-26]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=115, Expect=1e-25]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=115, Expect=2e-25]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=114, Expect=2e-25]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=113, Expect=5e-25]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=117, Expect=3e-26]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=117, Expect=1e-26]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=115, Expect=5e-26]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=115, Expect=6e-26]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=113, Expect=3e-25]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=112, Expect=6e-25]} {Dmel: FBgn0038837, CG3822, [Score=154, Expect=4e-38]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=228, Expect=7e-67]} {RNA1310_33468} |
5. | MligTC455_18891 | 275 | 5.73 | Mlig455_024941 | Neo: - Age: - Region-enriched R2: 2.016/0.02450 |
2.681 | 0.749 | - | 0.983 | - | 0.949 | - | Mlig455_024941 {REF} {Length: 394} {NoTransDecoderORF} {RNA1509_45136} {RNA1310_56753} {RNA815_28269} | |
6. | MligTC455_42792 | 201 | 4.19 | Mlig455_001356 | Neo: - Age: Up-Down-Down |
2.662 | 0.772 | - | 0.920 | - | 0.970 | - | Mlig455_001356 {REF} {Length: 1092} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_12950} {RNA1310_4155.1} {RNA815_15749.1} | |
7. | MligTC455_41870 | 67 | 1.39 | Mlig455_042417 | Neo: - Age: Up-Down-Up |
ANGPTL1 | 2.655 | 0.944 | - | 0.975 | - | 0.736 | - | Mlig455_042417 {REF} {Length: 1469} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=110.4]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=102, Expect=6e-24]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=99.8, Expect=3e-23]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=104, Expect=6e-25]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=99.4, Expect=4e-23]} {Dmel: FBgn0003326, sca, scabrous, [Score=89.4, Expect=1e-19]} {Celegans: WBGene00017013, ensh-1, [Score=55.1, Expect=2e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_28467} {RNA1310_67810} {RNA815_18070.1} |
8. | MligTC455_32392 | 63 | 1.31 | Mlig455_048146 | Neo: - Age: - |
SDCBP2 | 2.584 | 0.984 | - | 0.703 | - | 0.897 | - | Mlig455_048146 {REF} {Length: 895} {Pfam: PDZ domain [PF00595.26, score=47.3]; PDZ domain [PF17820.3, score=35.5]; PDZ domain [PF13180.8, score=31.4]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=60.1, Expect=1e-10]} {Mouse: ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=61.2, Expect=3e-11]} {Dmel: FBgn0263289, scrib, scribbled, [Score=46.6, Expect=4e-06]} {Celegans: WBGene00016678, C45G9.7, [Score=44.3, Expect=4e-06]} {Smed: dd_Smed_v6_11951_0_1, dd_Smed_v6_11951_0_1, [Score=90.5, Expect=1e-21]} {RNA1310_28491} {RNA815_52955} |
9. | MligTC455_40406 | 59 | 1.23 | Mlig455_062481 | Neo: - Age: - |
CHRNA9 | 2.571 | 0.957 | - | 0.771 | - | 0.843 | - | Mlig455_062481 {REF} {Length: 3660} {TRANSSPLICED} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.8]} {Human: ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=205, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=201, Expect=7e-58]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=2e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=1e-57]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=199, Expect=2e-57]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=4e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=196, Expect=1e-54]} {Mouse: ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=209, Expect=4e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=207, Expect=7e-60]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=200, Expect=6e-58]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=202, Expect=2e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=192, Expect=7e-55]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [RH, Score=449, Expect=5e-153]} {RNA1509_18288} {RNA1310_3728, RNA1509_18288} {RNA1509_18288, RNA815_3826.3} |
10. | MligTC455_50464 | 64 | 1.34 | Mlig455_007906, Mlig455_008010 | Neo: - Age: - |
2.568 | 0.996 | - | 0.784 | - | 0.788 | - | Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1} |
|
11. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 2.563 | 0.952 | - | 0.747 | - | 0.864 | - | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
12. | MligTC455_41130 | 1186 | 24.72 | Mlig455_000166, Mlig455_000179, Mlig455_067712 | Neo: - Age: Down-Up-Down Region-specific R2: 5.626 Region-enriched R2: 4.906/0.00009 Regeneration-downregulated R3: -5.200 Regeneration-depleted R3: -5.200 |
2.544 | 0.702 | - | 0.857 | - | 0.985 | - | Mlig455_000166 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_000179 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} Mlig455_067712 {REF} {Length: 479} {RNA1509_36590} {RNA1310_65705} |
|
13. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 2.442 | 0.752 | - | 0.970 | - | 0.720 | - | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
14. | MligTC455_38279 | 69 | 1.44 | Mlig455_045200 | Neo: - Age: - |
NOL4L | 2.442 | 0.983 | - | 0.724 | - | 0.735 | - | Mlig455_045200 {REF} {Length: 1997} {Human: ENSG00000197183, NOL4L, nucleolar protein 4 like, [RH, Score=150, Expect=9e-40]} {Mouse: ENSMUSG00000061411, Nol4l, nucleolar protein 4-like, [RH, Score=150, Expect=1e-39]} {Dmel: FBgn0283651, CG46301, [RH, Score=147, Expect=2e-37]} {Smed: dd_Smed_v6_27580_0_1, dd_Smed_v6_27580_0_1, [RH, Score=85.5, Expect=1e-17]} {RNA1310_76365.1} {RNA815_48196} |
15. | MligTC455_45033 | 23 | 0.47 | Mlig455_060160 | Neo: - Age: - |
1.986 | - | - | 0.998 | - | 0.988 | - | Mlig455_060160 {REF} {Length: 755} {Pfam: PAN domain [PF00024.28, score=25.5]} {RNA1310_44307} {RNA815_33128} | |
16. | MligTC455_44687 | 22 | 0.45 | Mlig455_061067 | Neo: - Age: - |
1.972 | - | - | 0.980 | - | 0.992 | - | Mlig455_061067 {REF} {Length: 2106} {Pfam: PAN domain [PF00024.28, score=19.4]} {RNA1509_27043} {RNA1310_39798} {RNA815_59357} | |
17. | MligTC455_14843 | 19 | 0.39 | Mlig455_064713 | Neo: - Age: - |
1.967 | - | - | 0.988 | - | 0.979 | - | Mlig455_064713 {REF} {Length: 1584} {RNA1310_60383} {RNA815_48502} | |
18. | MligTC455_53468 | 14 | 0.28 | Mlig455_070377 | Neo: - Age: - |
1.967 | - | - | 0.994 | - | 0.973 | - | Mlig455_070377 {REF} {Length: 2927} {Pfam: Glycine rich protein [PF12810.9, score=23.6]} {RNA1509_10020} {RNA1310_33363.2} {RNA815_25152} | |
19. | MligTC455_14842 | 21 | 0.45 | Mlig455_041074 | Neo: - Age: - |
1.963 | - | - | 0.989 | - | 0.974 | - | Mlig455_041074 {REF} {Length: 1383} {RNA1310_60383} {RNA815_48502} | |
20. | MligTC455_30852 | 46 | 0.96 | Mlig455_019345, Mlig455_019563, Mlig455_059135 | Neo: - Age: - |
GRIA2, GRIK2, GRIK4 | 1.961 | 0.969 | - | 0.992 | - | - | - | Mlig455_019345 {REF} {Length: 3399} {Pfam: Ligand-gated ion channel [PF00060.28, score=95.4]; Receptor family ligand binding region [PF01094.30, score=56.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=25.8]; Iron-containing alcohol dehydrogenase [PF13685.8, score=21.9]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=159, Expect=1e-39]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=157, Expect=9e-39]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=159, Expect=7e-40]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=155, Expect=2e-38]} {Dmel: FBgn0039927, CG11155, [Score=160, Expect=3e-40]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [RH, Score=281, Expect=4e-87]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} Mlig455_019563 {REF} {Length: 2692} {Pfam: Ligand-gated ion channel [PF00060.28, score=91.5]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=98.6, Expect=6e-23]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=95.9, Expect=5e-22]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=94.7, Expect=1e-21]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=96.7, Expect=2e-22]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=95.9, Expect=3e-22]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=94.7, Expect=9e-22]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=92.8, Expect=4e-21]} {Dmel: FBgn0038837, CG3822, [Score=99.4, Expect=2e-23]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=92.8, Expect=2e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=176, Expect=4e-53]} {RNA1310_21734.1} {RNA815_52393} Mlig455_059135 {REF} {Length: 3434} {Pfam: Receptor family ligand binding region [PF01094.30, score=58.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=45.1]; Iron-containing alcohol dehydrogenase [PF13685.8, score=23.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=71.6, Expect=2e-12]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=70.5, Expect=3e-12]} {Dmel: FBgn0038837, CG3822, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00001617, glr-6, GLutamate Receptor family (AMPA), [Score=68.6, Expect=6e-12]} {Smed: dd_Smed_v6_41723_0_2, dd_Smed_v6_41723_0_2, [Score=85.1, Expect=8e-18]} {RNA1509_10728} {RNA1310_122.1} {RNA815_8415.1} |
21. | MligTC455_32028 | 19 | 0.39 | Mlig455_019343, Mlig455_019346 | Neo: - Age: - |
GRIA2 | 1.959 | - | - | 0.994 | - | 0.965 | - | Mlig455_019343 {REF} {Length: 3241} {Pfam: Ligand-gated ion channel [PF00060.28, score=96.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=57.9]; Receptor family ligand binding region [PF01094.30, score=49.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.0]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=150, Expect=1e-36]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=149, Expect=2e-36]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=146, Expect=2e-35]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=144, Expect=9e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=144, Expect=1e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=150, Expect=5e-37]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=150, Expect=8e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=145, Expect=3e-35]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=3e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=144, Expect=5e-35]} {Dmel: FBgn0039927, CG11155, [Score=158, Expect=1e-39]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=125, Expect=3e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=250, Expect=2e-75]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.1} Mlig455_019346 {REF} {Length: 519} {Pfam: Receptor family ligand binding region [PF01094.30, score=21.5]} {RNA1509_10728} {RNA1310_4026} {RNA815_8415.2} |
22. | MligTC455_10899 | 46 | 0.95 | Mlig455_013784, Mlig455_013915 | Neo: - Age: - |
1.955 | - | - | 0.958 | - | 0.997 | - | Mlig455_013784 {REF} {Length: 1362} {Pfam: Glycine rich protein [PF12810.9, score=20.8]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} Mlig455_013915 {REF} {Length: 1516} {Pfam: Glycine rich protein [PF12810.9, score=20.3]} {RNA1509_28715} {RNA1310_91773} {RNA815_35307} |
|
23. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
1.949 | - | - | 0.995 | - | 0.954 | - | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
24. | MligTC455_53524 | 34 | 0.7 | Mlig455_010882 | Neo: - Age: - Region-enriched R2: 5.283/0.01696 |
1.949 | - | - | 0.980 | - | 0.969 | - | Mlig455_010882 {REF} {Length: 1818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=18.7]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=102, Expect=9e-24]} {RNA1310_45713} {RNA815_35716} | |
25. | MligTC455_01652 | 149 | 3.1 | Mlig455_018970 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.522/0.03301 |
1.948 | 0.976 | - | - | - | 0.972 | - | Mlig455_018970 {REF} {Length: 756} {Pfam: Pancreatic hormone peptide [PF00159.20, score=41.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [Score=40.0, Expect=7e-06]} {RNA1310_45503} {RNA815_39878} | |
26. | MligTC455_20784 | 11 | 0.23 | Mlig455_031697 | Neo: - Age: - |
1.947 | - | - | 0.961 | - | 0.986 | - | Mlig455_031697 {REF} {Length: 1362} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=60.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=40.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.5]} {Mouse: ENSMUSG00000048376, F2r, coagulation factor II (thrombin) receptor, [Score=58.9, Expect=3e-09]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=49.7, Expect=3e-06]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=77.8, Expect=2e-15]} {Smed: dd_Smed_v6_37609_0_1, dd_Smed_v6_37609_0_1, [Score=219, Expect=8e-69]} {RNA1310_74957} {RNA815_27680} | |
27. | MligTC455_40387 | 28 | 0.59 | Mlig455_019391 | Neo: - Age: Up-Down-Down |
1.944 | - | - | 0.981 | - | 0.963 | - | Mlig455_019391 {REF} {Length: 2094} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=146, Expect=1e-37]} {RNA1310_29891} {RNA815_15562} | |
28. | MligTC455_18269 | 27 | 0.56 | Mlig455_008658 | Neo: - Age: - |
1.941 | - | - | 0.991 | - | 0.950 | - | Mlig455_008658 {REF} {Length: 1290} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.1]} {RNA1509_25258} {RNA1310_4580, RNA1509_25258} {RNA1509_25258, RNA815_9496.1} | |
29. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 1.941 | - | - | 0.956 | - | 0.985 | - | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
30. | MligTC455_14293 | 27 | 0.55 | Mlig455_005699 | Neo: - Age: - |
1.94 | - | - | 0.990 | - | 0.950 | - | Mlig455_005699 {REF} {Length: 220} {NoTransDecoderORF} {RNA1509_35414} {RNA1310_4580} | |
31. | MligTC455_28693 | 60 | 1.26 | Mlig455_022354 | Neo: - Age: - |
1.94 | - | - | 0.953 | - | 0.987 | - | Mlig455_022354 {REF} {Length: 816} {Pfam: WSC domain [PF01822.21, score=53.0]; PAN domain [PF00024.28, score=20.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=48.1, Expect=2e-06]} {RNA1509_43359} {RNA1310_59466.1} {RNA815_19988} | |
32. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.939 | - | - | 0.976 | - | 0.963 | - | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
33. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
1.937 | - | - | 0.951 | - | 0.986 | - | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
34. | MligTC455_24924 | 19 | 0.39 | Mlig455_022395 | Neo: - Age: - |
1.932 | - | - | 0.953 | - | 0.979 | - | Mlig455_022395 {REF} {Length: 2109} {RNA1310_106878} | |
35. | MligTC455_16610 | 98 | 2.05 | Mlig455_069894 | Neo: - Age: - Region-enriched R2: 5.254/0.03136 |
WSCD2 | 1.93 | - | - | 0.943 | - | 0.987 | - | Mlig455_069894 {REF} {Length: 827} {Pfam: WSC domain [PF01822.21, score=59.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=55.1, Expect=4e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=9e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.4, Expect=2e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
36. | MligTC455_09730 | 7 | 0.15 | Mlig455_040086 | Neo: - Age: - |
ANGPTL2 | 1.929 | - | - | 0.942 | - | 0.987 | - | Mlig455_040086 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=142.1]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=111, Expect=1e-27]; ENSG00000130812, ANGPTL6, angiopoietin like 6, [Score=110, Expect=2e-27]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=109, Expect=6e-27]; ENSG00000160339, FCN2, ficolin 2, [Score=107, Expect=6e-27]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=110, Expect=2e-28]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=5e-27]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=108, Expect=9e-27]} {Dmel: FBgn0034160, CG5550, [Score=109, Expect=1e-28]} {Celegans: WBGene00020516, T15B7.1, [Score=62.4, Expect=4e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=101, Expect=1e-24]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241} |
37. | MligTC455_18586 | 93 | 1.93 | Mlig455_020226 | Neo: - Age: Down-Down-Up |
1.926 | - | - | 0.940 | - | 0.986 | - | Mlig455_020226 {REF} {Length: 1261} {RNA1310_64121} {RNA815_32233} | |
38. | MligTC455_43072 | 81 | 1.68 | Mlig455_042521 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.590/0.02161 |
1.925 | - | - | 0.944 | - | 0.981 | - | Mlig455_042521 {REF} {Length: 1049} {RNA1509_46101} {RNA1310_32444} {RNA815_30668} | |
39. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.921 | - | - | 0.980 | - | 0.941 | - | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
40. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.918 | - | - | 0.950 | - | 0.968 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
41. | MligTC455_31933 | 105 | 2.18 | Mlig455_062083 | Neo: - Age: - |
ANGPTL1 | 1.918 | - | - | 0.942 | - | 0.976 | - | Mlig455_062083 {REF} {Length: 1024} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=156.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=135, Expect=7e-36]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=132, Expect=2e-34]; ENSG00000101280, ANGPT4, angiopoietin 4, [Score=132, Expect=9e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=132, Expect=4e-35]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=130, Expect=2e-36]} {Celegans: WBGene00020516, T15B7.1, [Score=73.9, Expect=9e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=126, Expect=2e-32]} {RNA1509_14033} {RNA1310_32107.2} {RNA815_17173.3} |
42. | MligTC455_43963 | 1010 | 21.04 | Mlig455_015437 | Neo: - Age: Down-Down-Up Region-enriched R2: 2.083/0.01168 |
1.916 | - | - | 0.959 | - | 0.957 | - | Mlig455_015437 {REF} {Length: 612} {RNA1509_32160} {RNA1310_60746, RNA1509_32160} {RNA1509_32160, RNA815_30740} | |
43. | MligTC455_50288 | 118 | 2.47 | Mlig455_059182 | Neo: - Age: Up-Down-Down |
1.916 | - | - | 0.949 | - | 0.967 | - | Mlig455_059182 {REF} {Length: 3438} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=42.6]; Lectin C-type domain [PF00059.23, score=23.6]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [RH, Score=189, Expect=3e-53]} {RNA1509_45950, RNA1509_54781} {RNA1310_10757.1, RNA1509_45950, RNA1509_54781} {RNA1509_45950, RNA1509_54781, RNA815_5369} | |
44. | MligTC455_14715 | 31 | 0.65 | Mlig455_043609 | Neo: - Age: - |
ANGPTL1 | 1.915 | - | - | 0.949 | - | 0.966 | - | Mlig455_043609 {REF} {Length: 1252} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.2]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=131, Expect=2e-34]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=128, Expect=2e-33]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=2e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=129, Expect=7e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=128, Expect=2e-33]} {Dmel: FBgn0033312, CG8642, [RH, Score=122, Expect=1e-31]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=7e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
45. | MligTC455_42088 | 72 | 1.5 | Mlig455_028244 | Neo: - Age: - |
1.915 | 0.934 | - | - | - | 0.981 | - | Mlig455_028244 {REF} {Length: 2632} {RNA1509_40406} {RNA1310_12938} {RNA815_16887} | |
46. | MligTC455_05098 | 127 | 2.65 | Mlig455_009525, Mlig455_009531 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.095/0.01821 |
KCNH7 | 1.914 | - | - | 0.954 | - | 0.960 | - | Mlig455_009525 {REF} {Length: 2109} {Pfam: Ion transport protein [PF00520.33, score=111.8]; Ion channel [PF07885.18, score=46.1]; Cyclic nucleotide-binding domain [PF00027.31, score=36.3]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=29.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=528, Expect=4e-176]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=509, Expect=2e-170]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=505, Expect=9e-167]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=527, Expect=4e-175]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=510, Expect=3e-171]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=504, Expect=9e-167]} {Dmel: FBgn0003353, sei, seizure, [Score=507, Expect=2e-171]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=496, Expect=1e-169]} {Smed: dd_Smed_v6_12978_0_1, dd_Smed_v6_12978_0_1, [Score=608, Expect=0.0]} {RNA1509_56964} {RNA1310_41939} {RNA815_5858.1} Mlig455_009531 {REF} {Length: 3631} {Pfam: Ion transport protein [PF00520.33, score=110.4]; Ion channel [PF07885.18, score=45.2]; Cyclic nucleotide-binding domain [PF00027.31, score=43.3]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=619, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=597, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=596, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=617, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=602, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=596, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=591, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=579, Expect=0.0]} {Smed: dd_Smed_v6_12978_0_4, dd_Smed_v6_12978_0_4, [RH, Score=716, Expect=0.0]} {RNA1509_56964} {RNA1310_23186, RNA1509_56964} {RNA1509_56964, RNA815_5858.2} |
47. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.914 | - | - | 0.945 | - | 0.969 | - | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
48. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.913 | - | - | 0.922 | - | 0.991 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
49. | MligTC455_42840 | 147 | 3.06 | Mlig455_003645 | Neo: - Age: - |
1.91 | - | - | 0.986 | - | 0.924 | - | Mlig455_003645 {REF} {Length: 1270} {RNA1509_48973} {RNA1310_36721} {RNA815_36286} | |
50. | MligTC455_33845 | 53 | 1.1 | Mlig455_004238 | Neo: - Age: - |
1.908 | 0.973 | - | - | - | 0.935 | - | Mlig455_004238 {REF} {Length: 727} {NoTransDecoderORF} {RNA1310_127880.2} {RNA815_42471} | |
51. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
1.908 | - | - | 0.936 | - | 0.972 | - | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
52. | MligTC455_48656 | 24 | 0.5 | Mlig455_039647 | Neo: - Age: - |
1.907 | - | - | 0.970 | - | 0.937 | - | Mlig455_039647 {REF} {Length: 1715} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.7]} {RNA1310_48037} {RNA815_27969} | |
53. | MligTC455_48714 | 132 | 2.74 | Mlig455_037041 | Neo: - Age: - Region-enriched R2: 4.531/0.00493 |
1.907 | - | - | 0.958 | - | 0.949 | - | Mlig455_037041 {REF} {Length: 1099} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} | |
54. | MligTC455_52120 | 179 | 3.73 | Mlig455_024423, Mlig455_024577 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.068/0.01755 |
POU4F3 | 1.907 | - | - | 0.972 | - | 0.935 | - | Mlig455_024423 {REF} {Length: 1288} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} Mlig455_024577 {REF} {Length: 1325} {TRANSSPLICED} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=104.8]; Homeodomain [PF00046.31, score=60.9]} {Human: ENSG00000091010, POU4F3, POU class 4 homeobox 3, [Score=212, Expect=1e-65]; ENSG00000152192, POU4F1, POU class 4 homeobox 1, [Score=211, Expect=2e-64]} {Mouse: ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [Score=212, Expect=7e-66]; ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [Score=211, Expect=2e-64]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [Score=209, Expect=2e-64]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [Score=188, Expect=4e-57]} {Smed: dd_Smed_v6_30562_0_1, dd_Smed_v6_30562_0_1, [Score=208, Expect=2e-64]} {RNA1509_57422} {RNA1310_23131} {RNA815_34447} |
55. | MligTC455_19708 | 304 | 6.32 | Mlig455_009784 | Neo: - Age: - Region-enriched R2: 6.355/0.00039 |
1.906 | - | - | 0.959 | - | 0.947 | - | Mlig455_009784 {REF} {Length: 826} {Pfam: Pancreatic hormone peptide [PF00159.20, score=43.3]} {RNA1509_54211} {RNA1310_54505.1, RNA1509_54211} {RNA1509_54211, RNA815_29389} | |
56. | MligTC455_25596 | 16 | 0.33 | Mlig455_041992 | Neo: - Age: - |
CCDC42 | 1.905 | 0.915 | - | 0.990 | - | - | - | Mlig455_041992 {REF} {Length: 3339} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4200) [PF13863.8, score=104.3]} {Human: ENSG00000161973, CCDC42, coiled-coil domain containing 42, [Score=147, Expect=2e-41]} {Mouse: ENSMUSG00000045915, Ccdc42, coiled-coil domain containing 42, [Score=157, Expect=2e-45]} {Smed: dd_Smed_v6_12378_0_1, dd_Smed_v6_12378_0_1, [Score=209, Expect=3e-66]} {RNA1509_52279} {RNA1310_20865} {RNA815_15037.1} |
57. | MligTC455_40353 | 39 | 0.82 | Mlig455_024525 | Neo: - Age: - |
1.904 | - | - | 0.937 | - | 0.967 | - | Mlig455_024525 {REF} {Length: 1158} {RNA1310_29008} | |
58. | MligTC455_42044 | 14 | 0.28 | Mlig455_036295 | Neo: - Age: - |
1.904 | - | - | 0.958 | - | 0.946 | - | Mlig455_036295 {REF} {Length: 1775} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=32.8]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=62.8, Expect=8e-11]} {RNA1310_147392} | |
59. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.903 | - | - | 0.985 | - | 0.918 | - | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
60. | MligTC455_13963 | 31 | 0.64 | Mlig455_052027 | Neo: - Age: Down-Up-Down |
1.901 | - | - | 0.940 | - | 0.961 | - | Mlig455_052027 {REF} {Length: 1717} {RNA1509_48973} {RNA1310_34931} {RNA815_59614} | |
61. | MligTC455_18579 | 143 | 2.97 | Mlig455_047208, Mlig455_048469 | Neo: - Age: - |
GRIK2, GRIK3 | 1.9 | - | - | 0.975 | - | 0.925 | - | Mlig455_047208 {REF} {Length: 5413} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=92.5]; Ligand-gated ion channel [PF00060.28, score=84.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=49.2]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=194, Expect=2e-50]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=193, Expect=5e-50]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=192, Expect=2e-49]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=192, Expect=2e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=191, Expect=3e-49]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=194, Expect=1e-50]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=194, Expect=3e-50]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=191, Expect=2e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=191, Expect=2e-49]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=188, Expect=2e-48]} {Dmel: FBgn0038837, CG3822, [Score=185, Expect=9e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=200, Expect=7e-53]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=341, Expect=5e-106]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308} Mlig455_048469 {REF} {Length: 3740} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=95.9]; Ligand-gated ion channel [PF00060.28, score=82.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=51.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=190, Expect=6e-50]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=187, Expect=5e-49]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=185, Expect=3e-48]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=184, Expect=1e-47]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=189, Expect=7e-50]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=187, Expect=6e-49]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=185, Expect=2e-48]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=183, Expect=9e-48]} {Dmel: FBgn0038837, CG3822, [Score=183, Expect=4e-48]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=183, Expect=3e-48]} {Smed: dd_Smed_v6_17503_0_1, dd_Smed_v6_17503_0_1, [Score=338, Expect=6e-108]} {RNA1509_47157} {RNA1310_18671} {RNA815_30308} |
62. | MligTC455_37270 | 86 | 1.79 | Mlig455_022293 | Neo: - Age: - |
CASP3 | 1.9 | - | - | 0.979 | - | 0.921 | - | Mlig455_022293 {REF} {Length: 2773} {Pfam: Caspase domain [PF00656.24, score=93.1]; Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13857.8, score=62.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeat [PF00023.32, score=28.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=109, Expect=7e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]; ENSG00000165806, CASP7, caspase 7, [Score=104, Expect=2e-23]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=9e-25]; ENSMUSG00000031628, Casp3, caspase 3, [Score=103, Expect=3e-24]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=3e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_3121_1_1, dd_Smed_v6_3121_1_1, [Score=102, Expect=3e-24]} {RNA1509_54818} {RNA1310_7187, RNA1509_54818} {RNA1509_54818, RNA815_8712} |
63. | MligTC455_50296 | 55 | 1.15 | Mlig455_051593 | Neo: - Age: Up-Down-Up |
1.897 | 0.936 | - | - | - | 0.961 | - | Mlig455_051593 {REF} {Length: 2388} {RNA1310_48051} {RNA815_14784} | |
64. | MligTC455_14716 | 29 | 0.61 | Mlig455_043633 | Neo: - Age: - |
ANGPTL2 | 1.896 | - | - | 0.962 | - | 0.934 | - | Mlig455_043633 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=157.6]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=2e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=133, Expect=4e-35]; ENSG00000085265, FCN1, ficolin 1, [Score=132, Expect=8e-36]; ENSG00000160339, FCN2, ficolin 2, [Score=128, Expect=4e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=119, Expect=6e-32]} {Celegans: WBGene00017013, ensh-1, [Score=57.8, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=1e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
65. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
1.896 | - | - | 0.923 | - | 0.973 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
66. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.896 | - | - | 0.987 | - | 0.909 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
67. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 1.896 | - | - | 0.992 | - | 0.904 | - | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
68. | MligTC455_31901 | 18 | 0.38 | Mlig455_022355 | Neo: - Age: - |
1.895 | - | - | 0.931 | - | 0.964 | - | Mlig455_022355 {REF} {Length: 541} {Pfam: PAN domain [PF00024.28, score=19.0]} {RNA1310_125793} {RNA815_23776.1} | |
69. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 1.894 | - | - | 0.960 | - | 0.934 | - | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
70. | MligTC455_36152 | 137 | 2.84 | Mlig455_053279 | Neo: - Age: - Region-enriched R2: 3.782/0.03873 |
ZFYVE9 | 1.894 | 0.918 | - | - | - | 0.976 | - | Mlig455_053279 {REF} {Length: 2163} {Pfam: Domain of unknown function (DUF3480) [PF11979.10, score=106.6]} {Human: ENSG00000157077, ZFYVE9, zinc finger FYVE-type containing 9, [Score=132, Expect=5e-32]} {Mouse: ENSMUSG00000034557, Zfyve9, zinc finger, FYVE domain containing 9, [Score=134, Expect=7e-33]} {Dmel: FBgn0026369, Sara, Smad anchor for receptor activation, [Score=122, Expect=6e-29]} {Celegans: WBGene00000101, aka-1, A Kinase Anchor protein; A kinase anchor protein, [Score=50.1, Expect=3e-06]} {Smed: dd_Smed_v6_8098_0_1, dd_Smed_v6_8098_0_1, [Score=82.4, Expect=2e-16]} {RNA1509_39700} {RNA1310_6234.1} {RNA815_2939.1} |
71. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
1.892 | - | - | 0.994 | - | 0.898 | - | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
72. | MligTC455_17568 | 33 | 0.68 | Mlig455_059349, Mlig455_065584 | Neo: - Age: - |
1.892 | - | - | 0.956 | - | 0.936 | - | Mlig455_059349 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} Mlig455_065584 {REF} {Length: 1132} {RNA1509_24218} {RNA1310_25312.1} {RNA815_12390} |
|
73. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 1.889 | - | - | 0.982 | - | 0.907 | - | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
74. | MligTC455_16248 | 132 | 2.74 | Mlig455_038325, Mlig455_050222, Mlig455_050231 | Neo: - Age: - |
CHRNA3 | 1.889 | - | - | 0.950 | - | 0.939 | - | Mlig455_038325 {REF} {Length: 1078} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=200.0]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=192, Expect=4e-57]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=194, Expect=7e-58]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=190, Expect=1e-56]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=206, Expect=1e-62]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=186, Expect=4e-55]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=216, Expect=5e-67]} {RNA1310_44575} {RNA815_22042} Mlig455_050222 {REF} {Length: 2164} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=202.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=197.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=348, Expect=5e-114]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=335, Expect=4e-109]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=348, Expect=2e-114]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=343, Expect=2e-112]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=335, Expect=5e-109]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=397, Expect=1e-133]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=338, Expect=2e-110]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=489, Expect=5e-170]} {RNA1310_44575} {RNA815_22042} Mlig455_050231 {REF} {Length: 2219} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=203.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=143.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=304, Expect=5e-99]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=299, Expect=8e-97]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=293, Expect=2e-94]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=290, Expect=7e-92]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=302, Expect=3e-98]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=296, Expect=3e-96]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=291, Expect=5e-94]} {Dmel: FBgn0000036, nAChRalpha1, nicotinic Acetylcholine Receptor alpha1, [Score=352, Expect=8e-117]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=303, Expect=5e-99]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=424, Expect=2e-146]} {RNA1310_44575} {RNA815_22042} |
75. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.888 | - | - | 0.961 | - | 0.927 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
76. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1.887 | - | - | 0.995 | - | 0.892 | - | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
77. | MligTC455_50349 | 31 | 0.65 | Mlig455_043966 | Neo: - Age: - |
1.887 | - | - | 0.931 | - | 0.956 | - | Mlig455_043966 {REF} {Length: 615} {NoTransDecoderORF} {RNA1509_42587} {RNA1310_27550.1} {RNA815_55700} | |
78. | MligTC455_09405 | 6 | 0.12 | Mlig455_069593 | Neo: - Age: - |
FCN1 | 1.886 | - | - | 0.990 | - | 0.896 | - | Mlig455_069593 {REF} {Length: 1062} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=116.0]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=111, Expect=5e-28]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000028001, Fga, fibrinogen alpha chain, [Score=100, Expect=4e-23]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=4e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=98.6, Expect=1e-22]} {Dmel: FBgn0003326, sca, scabrous, [Score=105, Expect=5e-25]} {Celegans: WBGene00020516, T15B7.1, [Score=62.8, Expect=5e-11]} {Smed: dd_Smed_v6_74244_0_1, dd_Smed_v6_74244_0_1, [Score=44.3, Expect=7e-06]} |
79. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 1.885 | - | - | 0.994 | - | 0.891 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
80. | MligTC455_32644 | 41 | 0.86 | Mlig455_043770, Mlig455_043786 | Neo: - Age: - Region-enriched R2: 6.705/0.00336 |
1.884 | - | - | 0.997 | - | 0.887 | - | Mlig455_043770 {REF} {Length: 1011} {Pfam: PAN domain [PF00024.28, score=19.3]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=60.8, Expect=3e-11]} {RNA1509_35604} {RNA1310_57814} {RNA815_29718} Mlig455_043786 {REF} {Length: 1348} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1509_35604} {RNA1310_34182} {RNA815_29718} |
|
81. | MligTC455_52349 | 99 | 2.06 | Mlig455_011056 | Neo: - Age: - |
DGKI | 1.884 | - | - | 0.925 | - | 0.959 | - | Mlig455_011056 {REF} {Length: 3706} {Pfam: Diacylglycerol kinase accessory domain [PF00609.21, score=146.1]; Diacylglycerol kinase catalytic domain [PF00781.26, score=101.1]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=31.0]; Proline-rich protein family 20 [PF15708.7, score=21.0]} {Human: ENSG00000157680, DGKI, diacylglycerol kinase iota, [Score=677, Expect=0.0]; ENSG00000149091, DGKZ, diacylglycerol kinase zeta, [Score=672, Expect=0.0]} {Mouse: ENSMUSG00000038665, Dgki, diacylglycerol kinase, iota, [Score=682, Expect=0.0]; ENSMUSG00000040479, Dgkz, diacylglycerol kinase zeta, [Score=667, Expect=0.0]} {Dmel: FBgn0261549, rdgA, retinal degeneration A, [Score=533, Expect=8e-173]} {Celegans: WBGene00019428, dgk-5, Putative diacylglycerol kinase K06A1.6, [RH, Score=491, Expect=4e-158]} {Smed: dd_Smed_v6_12579_0_4, dd_Smed_v6_12579_0_4, [Score=629, Expect=0.0]} {RNA1509_51540} {RNA1310_9558, RNA1509_51540} {RNA1509_51540, RNA815_11195} |
82. | MligTC455_45285 | 7 | 0.14 | Mlig455_046883 | Neo: - Age: - |
1.883 | - | - | 0.991 | - | 0.892 | - | Mlig455_046883 {REF} {Length: 2303} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]} {Celegans: WBGene00008885, F16C3.1, [RH, Score=57.0, Expect=2e-08]} {Smed: dd_Smed_v6_26560_0_2, dd_Smed_v6_26560_0_2, [Score=80.5, Expect=3e-16]} {RNA1509_24228} {RNA1310_11273} | |
83. | MligTC455_10968 | 7 | 0.14 | Mlig455_015698 | Neo: - Age: - |
HMCN1 | 1.882 | - | - | 0.990 | - | 0.892 | - | Mlig455_015698 {REF} {Length: 1150} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=52.4, Expect=5e-07]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=60.5, Expect=6e-10]} {Celegans: WBGene00000082, adt-1, ADAMTS family; ADT-1, [Score=51.6, Expect=2e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=60.1, Expect=4e-10]} {RNA1310_100476} {RNA815_63742} |
84. | MligTC455_14795 | 8 | 0.16 | Mlig455_001604 | Neo: - Age: - |
NPR1 | 1.882 | - | - | 0.990 | - | 0.892 | - | Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875} |
85. | MligTC455_41107 | 31 | 0.64 | Mlig455_024003, Mlig455_055882 | Neo: - Age: - |
1.882 | - | - | 0.907 | - | 0.975 | - | Mlig455_024003 {REF} {Length: 1460} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=47.7]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=173, Expect=1e-52]} {RNA1310_46591} Mlig455_055882 {REF} {Length: 1280} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.4]} {Smed: dd_Smed_v6_2174_0_1, dd_Smed_v6_2174_0_1, [Score=152, Expect=1e-44]} {RNA1310_46591} |
|
86. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
1.881 | - | - | 0.992 | - | 0.889 | - | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
87. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
1.881 | - | - | 0.889 | - | 0.992 | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
88. | MligTC455_38682 | 102 | 2.12 | Mlig455_039641 | Neo: - Age: - Region-enriched R2: 6.138/0.02363 |
SLC18A3 | 1.881 | - | - | 0.914 | - | 0.967 | - | Mlig455_039641 {REF} {Length: 3925} {Pfam: Major Facilitator Superfamily [PF07690.18, score=147.1]; Sugar (and other) transporter [PF00083.26, score=29.0]; LacY proton/sugar symporter [PF01306.21, score=20.2]} {Human: ENSG00000187714, SLC18A3, solute carrier family 18 member A3, [RH, Score=469, Expect=9e-161]} {Mouse: ENSMUSG00000100241, Slc18a3, solute carrier family 18 (vesicular monoamine), member 3, [RH, Score=469, Expect=1e-160]} {Dmel: FBgn0270928, VAChT, Vesicular acetylcholine transporter, [RH, Score=513, Expect=2e-177]} {Celegans: WBGene00006756, unc-17, Vesicular acetylcholine transporter unc-17, [RH, Score=486, Expect=2e-167]} {Smed: dd_Smed_v6_11630_0_1, dd_Smed_v6_11630_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_28397} {RNA815_32284.1} |
89. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
1.881 | - | - | 0.993 | - | 0.888 | - | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
90. | MligTC455_42590 | 32 | 0.67 | Mlig455_050244 | Neo: - Age: - |
GALR2 | 1.879 | - | - | 0.907 | - | 0.972 | - | Mlig455_050244 {REF} {Length: 1946} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=169.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=40.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=33.4]; Olfactory receptor [PF13853.8, score=23.0]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=20.6]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=164, Expect=4e-46]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=160, Expect=6e-45]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [RH, Score=216, Expect=6e-66]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [RH, Score=208, Expect=1e-62]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=282, Expect=6e-91]} {RNA1310_75607} {RNA815_49665} |
91. | MligTC455_42473 | 118 | 2.46 | Mlig455_016841, Mlig455_016854, Mlig455_070015 | Neo: - Age: - |
1.878 | 0.928 | - | 0.950 | - | - | - | Mlig455_016841 {REF} {Length: 587} {RNA1310_62504} {RNA815_41252} Mlig455_016854 {REF} {Length: 587} {RNA1310_62504} {RNA815_41252} Mlig455_070015 {REF} {Length: 600} {RNA1310_62504} {RNA815_41252} |
|
92. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 1.876 | - | - | 0.957 | - | 0.919 | - | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
93. | MligTC455_40444 | 2996 | 62.42 | Mlig455_039527, Mlig455_051318 | Neo: - Age: Down-Up-Down |
1.875 | - | - | 0.925 | - | 0.950 | - | Mlig455_039527 {REF} {Length: 710} {RNA1509_7655} {RNA1310_63393} {RNA815_30324} Mlig455_051318 {REF} {Length: 721} {RNA1509_7655} {RNA1310_63393, RNA1509_7655} {RNA1509_7655, RNA815_30324} |
|
94. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 1.874 | - | - | 0.989 | - | 0.885 | - | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
95. | MligTC455_40289 | 93 | 1.94 | Mlig455_017727, Mlig455_056175 | Neo: - Age: - |
BMP1, CUBN | 1.874 | - | - | 0.908 | - | 0.966 | - | Mlig455_017727 {REF} {Length: 1202} {Pfam: CUB domain [PF00431.22, score=55.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=54.7, Expect=4e-08]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.0, Expect=3e-07]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=51.6, Expect=3e-07]; ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.4, Expect=2e-07]} {RNA1310_48745} {RNA815_23305} Mlig455_056175 {REF} {Length: 2747} {Pfam: CUB domain [PF00431.22, score=62.6]} {Human: ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=52.8, Expect=2e-07]; ENSG00000107611, CUBN, cubilin, [Score=51.6, Expect=4e-07]} {Mouse: ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=51.6, Expect=3e-07]; ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=49.7, Expect=1e-06]} {Dmel: FBgn0003719, tld, tolloid, [Score=51.2, Expect=3e-07]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=47.0, Expect=3e-07]} {RNA1310_48745} {RNA815_23305} |
96. | MligTC455_39064 | 110 | 2.28 | Mlig455_000222, Mlig455_058480 | Neo: Irradiation Age: - Region-enriched R2: 5.418/0.00017 |
OSBPL1A | 1.869 | - | - | 0.899 | - | 0.970 | - | Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740} Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411} |
97. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.868 | - | - | 0.965 | - | 0.903 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
98. | MligTC455_19850 | 21 | 0.44 | Mlig455_016817 | Neo: - |
GUCY1B1 | 1.867 | - | - | 0.993 | - | 0.874 | - | Mlig455_016817 {REF} {Length: 2782} {Pfam: Heme NO binding associated [PF07701.16, score=218.0]; Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=199.9]; Haem-NO-binding [PF07700.17, score=175.1]} {Human: ENSG00000061918, GUCY1B1, guanylate cyclase 1 soluble subunit beta 1, [Score=338, Expect=4e-107]} {Mouse: ENSMUSG00000028005, Gucy1b1, guanylate cyclase 1, soluble, beta 1, [Score=342, Expect=6e-109]; ENSMUSG00000021933, Gucy1b2, guanylate cyclase 1, soluble, beta 2, [Score=339, Expect=1e-105]} {Dmel: FBgn0038295, Gyc88E, Guanylyl cyclase at 88E, [RH, Score=593, Expect=0.0]} {Celegans: WBGene00001551, gcy-31, Soluble guanylate cyclase gcy-31, [RH, Score=513, Expect=2e-174]} {Smed: dd_Smed_v6_18111_0_1, dd_Smed_v6_18111_0_1, [RH, Score=823, Expect=0.0]} {RNA1509_55074} {RNA1310_24262} {RNA815_41754} |
99. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 1.866 | - | - | 0.902 | - | 0.964 | - | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
100. | MligTC455_43690 | 262 | 5.46 | Mlig455_035029, Mlig455_053437 | Neo: - Age: - Region-enriched R2: 6.108/0.00708 |
WSCD2 | 1.866 | 0.989 | - | 0.877 | - | - | - | Mlig455_035029 {REF} {Length: 893} {Pfam: WSC domain [PF01822.21, score=50.2]; PAN domain [PF00024.28, score=29.7]} {RNA1310_42429} {RNA815_24291.1} Mlig455_053437 {REF} {Length: 972} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=29.7]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=44.7, Expect=1e-05]} {RNA1310_42429} {RNA815_24291.1} |